Lilly to acquire Centessa in deal worth up to $7.8bn
The companies aim to advance treatments for narcolepsy and other sleep-wake disorders
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Roche opens new Swiss Institute of Human Biology research facility
The new building is part of a 1.5bn euro site investment
Lilly to acquire Centessa in deal worth up to $7.8bn
The companies aim to advance treatments for narcolepsy and other sleep-wake disorders
Lilly’s Foundayo approved by US FDA as oral GLP-1 for weight loss
Taken at any time of the day, the oral GLP-1 is the only pill to have no food or water restrictions
Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development
The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients
Copenhagen Airports A/S, SAS Cargo and World Courier to host FlyPharma 2026
The conference will take place from 6 to 7 October 2026 in Copenhagen, Denmark
Latest content
Takeda’s CEO-elect, Julie Kim, proposed as new candidate for Board of Directors
The company has also proposed new candidates for director appointments
Read More
Matt Ferriday announced as General Manager for LEO Pharma UK
Ferriday most recently held senior leadership roles at Ipsen Biopharma
Read More
ReproNovo appoints Mark Altmeyer as Chairman of the Board
Altmeyer previously held senior roles at Arvelle Therapeutics, Axovant, Bristol Myers Squibb and Otsuka
Read More
Poolbeg Pharma appoints Adrian Kilcoyne to Scientific Advisory Board
Kilcoyne previously held senior roles at AstraZeneca, Celgene, Sanofi, Roche and Eli Lilly
Read More
Intelligence
The digital age and the advance of AI – pushing communications to new heights
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read More
GenAI: embracing the transformation – with caution
Despite the GenAI fervour, there is an acute need to prepare organisations to understand which specific tools they need and how to use them
Read More
The race to explore and harness GenAI in healthcare
AI has graduated from being a procurer of efficiencies to seemingly an enabler of unimagined possibilities
Read More
Communication breakdown
Why soft skills are more important than ever in life sciences
Read More
Medicine shortages strike again – can radio-frequency identification technology help?
RFID has emerged as a key technology for its rapid, accurate data capture, and track and trace capabilities for manufacturing and supply chain operations
Read More
Pandemic readiness is now a financial risk test – and the UK must treat it that way
COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation and exposing governance weaknesses
Read More
Blogs
Latest
NEW WEBINAR: Maximizing Speed-to-Outcome for Life Science Companies
April 2, 2026 | Impetus Digital|Advisory board, Pharma trends, Virtual Pharma, asset cocreatio, life science outomes, life science webinar, pharma collaboration, pharma webinar, quality improvement plan, real-world evidence, speed to insight, virtual tools, webinar
Stop losing momentum to the “logistics lag.” The most successful life science teams have moved beyond fragmented spreadsheets and isolated meetings into a unified orchestration …
Insight gaps leave Biopharma vulnerable to patent cliff crisis, warns expert
April 1, 2026 | Nmblr|Patent cliffs; commercialisation strategy; innovation; biosimilars; biopharma;
With unprecedented patent cliffs looming, putting an estimated $200 to $400 billion in annual global sales at risk , senior strategy consultant and Nmblr founder, …
HRW Wins 2026 Artificial Intelligence Excellence Award in the Pharmaceutical Category
March 26, 2026 | Healthcare Research Worldwide|AI, Avatars, Innovation, artificial intelligence, market research
Healthcare Research Worldwide (HRW) has been named a winner in the 2026 Artificial Intelligence Excellence Awards in the Pharmaceutical category, recognizing its innovative use of …
Amiculum reaffirms presence in Dundee with new office and continued academic partnership
March 26, 2026 | Amiculum|Dundee, life sciences
Amiculum is pleased to announce the relocation of its Dundee team to a new, state-of-the-art facility at the Dundee Life Sciences Innovation Hub, an environment …
GRACE COMMS acquisition of WORDBIRD creates a merger of two independent, strategic and creative healthcare agencies
March 25, 2026 | Grace Communications|Agency news, Grace Communications, Wordbird, acquisition
We are delighted to announce that Grace Comms and Wordbird Limited, both healthcare brand comms agencies with a creative mission in healthcare and a passion …
The invisible influence on trial retention: why caregivers must be part of the plan
April 10, 2026 | Cuttsy + Cuttsy|Participation, Trial retention, caregivers, carers, clinical trials
Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.
Where it all began: why we wrote ‘The Site Factor’
April 8, 2026 | Cuttsy + Cuttsy|Clinical Sites, Participant engagement, Site Teams, clinical trials
Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.
PharmaQuest returns: EPA perspectives, through a rare disease lens
April 7, 2026 | Amiculum|EPA, First‑in‑class innovation, PharmaQuest, Quality of life (QoL), ispor, rare diseases
By Lottie Sequerra and Emily Morton-West
From text to context: Helping patients see side effects clearly
March 30, 2026 | Cuttsy + Cuttsy|health information, health literacy, healthcare communications
Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health …
Amiculum meets Paul Tunnah: Pharma’s adoption of AI in healthcare communications
March 26, 2026 | Amiculum|artificial intelligence
By Steve Wilson